REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB

被引：0
|
作者：
Raluy-Callado, Mireia
Carroll, Robert
Curtis, Rebecca
Khalid, Javaria Mona
Patel, Haridarshan
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 01期
关键词：
D O I：
10.1053/j.gastro.2017.11.249
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P190
引用
收藏
页码：S105 / S106
页数：2
相关论文
共 50 条
  • [41] Articular manifestations in patients with inflammatory bowel disease treated with vedolizumab
    Dupre, Anastasia
    Collins, Michael
    Nocturne, Gaetane
    Carbonnel, Franck
    Mariette, Xavier
    Seror, Raphaele
    RHEUMATOLOGY, 2020, 59 (11) : 3275 - 3283
  • [42] ARTICULAR MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Dupre, Anastasia
    Collins, Michael
    Carbonnel, Franck
    Mariette, Xavier
    Nocturne, Gaetane
    Seror, Raphaele
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1240 - 1241
  • [43] MUSCULOSKELETAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Rodriguez-Merlos, P.
    Ruiz-Ramirez, M. A.
    Plasencia, C.
    Navarro-Compan, V.
    Suarez-Ferrer, C.
    Martin-Arranz, E.
    Martin Arranz, M. D.
    Peiteado, D.
    Bonilla, G.
    Sanchez Azofra, M.
    Poza Cordon, J.
    Franco Gomez, K. N.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 731 - 732
  • [44] Efficacy of vedolizumab and ustekinumab in pediatric-onset inflammatory bowel disease: A real-world multicenter study
    Rebus, Soleynne
    Coopman, Stephanie
    Djeddi, Djamal
    Vanrenterghem, Audrey
    Dupont, Claire
    Lacotte, Edouard
    Ley, Delphine
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2025, 80 (01): : 113 - 123
  • [45] Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience
    Kopylov, Uri
    Ron, Yulia
    Avni-Biron, Irit
    Koslowsky, Benjamin
    Waterman, Matti
    Daher, Saleh
    Ungar, Bella
    Yanai, Henit
    Maharshak, Nitsan
    Ben-Bassat, Ofer
    Lichtenstein, Lev
    Shitrit, Ariella Bar-Gil
    Israeli, Eran
    Schwartz, Doron
    Zittan, Eran
    Eliakim, Rami
    Chowers, Yehuda
    Ben-Horin, Shomron
    Dotan, Iris
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (03) : 404 - 408
  • [46] The Clinical Course of Bowel Urgency Severity Among Patients with Inflammatory Bowel Disease-A Real-World Study
    Lewis, James D.
    Gibble, Theresa Hunter
    Shan, Mingyang
    Zhou, Xian
    Naegeli, April N.
    Dawwas, Ghadeer K.
    DRUGS-REAL WORLD OUTCOMES, 2024, 11 (03) : 403 - 412
  • [47] PATIENTS WITH CROHN'S DISEASE TREATED WITH USTEKINUMAB VERSUS VEDOLIZUMAB IN REAL-WORLD SETTINGS
    Chiorean, Michael V.
    Jiang, Jeanne
    Candela, Ninfa
    Chen, Grace
    Romdhani, Hela
    Latremouille-Viau, Dominick
    Shi, Sherry
    Bungay, Rebecca
    Fan, Tao
    GASTROENTEROLOGY, 2020, 158 (06) : S407 - S408
  • [48] RISK OF INFECTIOUS COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH VEDOLIZUMAB: A REAL LIFE EXPERIENCE
    Apolito, P.
    Innocenti, T.
    Roselli, J.
    Parisio, L.
    Macri, G.
    Bagnoli, S.
    Rogai, F.
    Galli, A.
    Milla, M.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S123 - S123
  • [49] USE OF DIFFERENT STATISTICAL APPROACHES TO COMPARE REAL-WORLD OUTCOMES ASSOCIATED WITH VEDOLIZUMAB VERSUS INFLIXIMAB IN BIOLOGIC-NAIVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Latremouille-Viau, D.
    Burne, R.
    Shi, S.
    Patel, H.
    VALUE IN HEALTH, 2019, 22 : S178 - S178
  • [50] Effectiveness and safety of vedolizumab in real-world studies in Chinese patients with inflammatory bowel disease: a systematic review and meta-analysis
    Gu, Y.
    Zhang, X.
    Gu, L.
    Zou, D.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1920 - I1922
12345